Exact Mass: 447.2904
Exact Mass Matches: 447.2904
Found 396 metabolites which its exact mass value is equals to given mass value 447.2904
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Sisomicin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic KEIO_ID S047; [MS3] KO009246 KEIO_ID S047; [MS2] KO009245 KEIO_ID S047
benzethonium chloride
D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AJ - Quaternary ammonium compounds C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents Same as: D01140 Benzethonium chloride inhibits nicotinic acetylcholine receptors in human recombinant α7 and α4β2 neurons in Xenopus laevis oocytes.
N-Stearoyl tyrosine
N-stearoyl tyrosine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Stearic acid amide of Tyrosine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Stearoyl tyrosine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Stearoyl tyrosine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
(8Z,11Z,14Z,17Z)-Icosa-8,11,14,17-tetraenoylcarnitine
(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoylcarnitine is an acylcarnitine. More specifically, it is an (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
Tyrosyl-prolyl-leucyl-glycinamide
Esculeogenin A
Lilopristone
Tyr-pro-leu-gly-NH2
16-feruloyloxypalmitate
16-feruloyloxypalmitate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 16-feruloyloxypalmitate can be found in a number of food items such as mixed nuts, kiwi, soft-necked garlic, and sunflower, which makes 16-feruloyloxypalmitate a potential biomarker for the consumption of these food products.
(6Z,13E,21E)-(16R,20R)-20-hydroxy-16-methyl-10-phenyl-[14]cytochalasa-6,13,21-triene-1,23-dione
(1alpha,7beta,14alpha,16beta)-20-ethyl-1,8,16-trimethoxy-4-methylaconitan-14-yl acetate|14-acetoxy-8-O-methylsachaconitine
N-(3alpha-Hydroxy-7-oxo-5beta-cholanoyl-(24))-glycin|nutriaglycocholic acid|Nutriaglykocholsaeure
N-((4R)-4-((3R,5S,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)-N-methylglycine
Ala Lys Met Val
Ala Lys Val Met
Ala Met Lys Val
Ala Met Val Lys
Ala Arg Thr Thr
Ala Thr Arg Thr
Ala Thr Thr Arg
Ala Val Lys Met
Ala Val Met Lys
Cys Lys Val Val
Cys Val Lys Val
Cys Val Val Lys
Phe Gly Lys Pro
Phe Gly Pro Lys
Phe Lys Gly Pro
Phe Lys Pro Gly
Phe Pro Gly Lys
Phe Pro Lys Gly
Gly Phe Lys Pro
Gly Phe Pro Lys
Gly Ile Lys Met
Gly Ile Met Lys
Gly Lys Phe Pro
Gly Lys Ile Met
Gly Lys Leu Met
Gly Lys Met Ile
Gly Lys Met Leu
Gly Lys Pro Phe
Gly Leu Lys Met
Gly Leu Met Lys
Gly Met Ile Lys
Gly Met Lys Ile
Gly Met Lys Leu
Gly Met Leu Lys
Gly Pro Phe Lys
Gly Pro Lys Phe
Ile Gly Lys Met
Ile Gly Met Lys
Ile Lys Gly Met
Ile Lys Met Gly
Ile Lys Ser Thr
Ile Lys Thr Ser
Ile Met Gly Lys
Ile Met Lys Gly
Ile Ser Lys Thr
Ile Ser Thr Lys
Ile Thr Lys Ser
Ile Thr Ser Lys
Lys Ala Met Val
Lys Ala Val Met
Lys Cys Val Val
Lys Phe Gly Pro
Lys Phe Pro Gly
Lys Gly Phe Pro
Lys Gly Ile Met
Lys Gly Leu Met
Lys Gly Met Ile
Lys Gly Met Leu
Lys Gly Pro Phe
Lys Ile Gly Met
Lys Ile Met Gly
Lys Ile Ser Thr
Lys Ile Thr Ser
Lys Leu Gly Met
Lys Leu Met Gly
Lys Leu Ser Thr
Lys Leu Thr Ser
Lys Met Ala Val
Lys Met Gly Ile
Lys Met Gly Leu
Lys Met Ile Gly
Lys Met Leu Gly
Lys Met Val Ala
Lys Pro Phe Gly
Lys Pro Gly Phe
Lys Ser Ile Thr
Lys Ser Leu Thr
Lys Ser Thr Ile
Lys Ser Thr Leu
Lys Thr Ile Ser
Lys Thr Leu Ser
Lys Thr Ser Ile
Lys Thr Ser Leu
Lys Thr Thr Val
Lys Thr Val Thr
Lys Val Ala Met
Lys Val Cys Val
Lys Val Met Ala
Lys Val Thr Thr
Lys Val Val Cys
Leu Gly Lys Met
Leu Gly Met Lys
Leu Lys Gly Met
Leu Lys Met Gly
Leu Lys Ser Thr
Leu Lys Thr Ser
Leu Met Gly Lys
Leu Met Lys Gly
Leu Ser Lys Thr
Leu Ser Thr Lys
Leu Thr Lys Ser
Leu Thr Ser Lys
Met Ala Lys Val
Met Ala Val Lys
Met Gly Ile Lys
Met Gly Lys Ile
Met Gly Lys Leu
Met Gly Leu Lys
Met Ile Gly Lys
Met Ile Lys Gly
Met Lys Ala Val
Met Lys Gly Ile
Met Lys Gly Leu
Met Lys Ile Gly
Met Lys Leu Gly
Met Lys Val Ala
Met Leu Gly Lys
Met Leu Lys Gly
Met Val Ala Lys
Met Val Lys Ala
Pro Phe Gly Lys
Pro Phe Lys Gly
Pro Gly Phe Lys
Pro Gly Lys Phe
Pro Lys Phe Gly
Pro Lys Gly Phe
Arg Ala Thr Thr
Arg Ser Ser Val
Arg Ser Val Ser
Arg Thr Ala Thr
Arg Thr Thr Ala
Arg Val Ser Ser
Ser Ile Lys Thr
Ser Ile Thr Lys
Ser Lys Ile Thr
Ser Lys Leu Thr
Ser Lys Thr Ile
Ser Lys Thr Leu
Ser Leu Lys Thr
Ser Leu Thr Lys
Ser Arg Ser Val
Ser Arg Val Ser
Ser Ser Arg Val
Ser Ser Val Arg
Ser Thr Ile Lys
Ser Thr Lys Ile
Ser Thr Lys Leu
Ser Thr Leu Lys
Ser Val Arg Ser
Ser Val Ser Arg
Thr Ala Arg Thr
Thr Ala Thr Arg
Thr Ile Lys Ser
Thr Ile Ser Lys
Thr Lys Ile Ser
Thr Lys Leu Ser
Thr Lys Ser Ile
Thr Lys Ser Leu
Thr Lys Thr Val
Thr Lys Val Thr
Thr Leu Lys Ser
Thr Leu Ser Lys
Thr Arg Ala Thr
Thr Arg Thr Ala
Thr Ser Ile Lys
Thr Ser Lys Ile
Thr Ser Lys Leu
Thr Ser Leu Lys
Thr Thr Ala Arg
Thr Thr Lys Val
Thr Thr Arg Ala
Thr Thr Val Lys
Thr Val Lys Thr
Thr Val Thr Lys
Val Ala Lys Met
Val Ala Met Lys
Val Cys Lys Val
Val Cys Val Lys
Val Lys Ala Met
Val Lys Cys Val
Val Lys Met Ala
Val Lys Thr Thr
Val Lys Val Cys
Val Met Ala Lys
Val Met Lys Ala
Val Arg Ser Ser
Val Ser Arg Ser
Val Ser Ser Arg
Val Thr Lys Thr
Val Thr Thr Lys
Val Val Cys Lys
Val Val Lys Cys
2-[4-[[1-(3-oxo-3-phenylpropyl)benzimidazol-2-yl]methyl]piperazin-1-yl]-N-propan-2-ylacetamide
hexadecyl-(2-hydroxycyclohexyl)-dimethylazanium,bromide
benzethonium chloride
D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AJ - Quaternary ammonium compounds C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents Benzethonium chloride inhibits nicotinic acetylcholine receptors in human recombinant α7 and α4β2 neurons in Xenopus laevis oocytes.
H-DL-Tyr-DL-Pro-DL-Leu-Gly-NH2
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
7-Oxoglycochenodeoxycholic acid
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
4,6-Diamino-3-{[3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl]oxy}-2-hydroxycyclohexyl 3-deoxy-4-c-methyl-3-(methylamino)pentopyranoside
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors
Tyrosyl-prolyl-leucyl-glycinamide
(2S,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol
11-[4-(dimethylamino)phenyl]-17-hydroxy-17-[(E)-3-hydroxyprop-1-enyl]-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
(8Z,11Z,14Z,17Z)-Icosa-8,11,14,17-tetraenoylcarnitine
Esculeogenin A
A sapogenin that is spirosolane substituted by hydroxy groups at positions 3, 23 and 27 (the 3beta,5alpha,22alpha,23S,25S stereoisomer).
N-[2-[bis(2-methylpropyl)amino]ethyl]-2-[[5-methyl-2-(4-methylphenyl)-4-oxazolyl]methylsulfinyl]acetamide
1-[[2-(4-ethylphenyl)-5-methyl-4-oxazolyl]methyl]-N-[(2-methoxyphenyl)methyl]-4-piperidinecarboxamide
(2S,3R,4S,5S)-2-[(1R,2S,3S,4R,6S)-4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol
(4E,6Z)-N-(5-ethyl-5-methyl-2-oxofuran-3-yl)-3-hydroxy-8-(3-nonyloxiran-2-yl)octa-4,6-dienamide
4-[2-[2,4-Bis(4-ethoxyphenyl)-6-methyl-1-pyridin-1-iumyl]ethyl]morpholine
N-[(5R,6S,9R)-8-(cyclopropylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5S,6R,9R)-8-(cyclopropylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5R,6R,9R)-8-(cyclopropylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5S,6R,9S)-8-(cyclopropylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5S,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(5S,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(5R,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
4-[(3aR,4S,9bS)-1-[cyclobutyl(oxo)methyl]-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
N-((4R)-4-((3R,5S,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)-N-methylglycine
N-[(5R,6R,9S)-8-(cyclopropylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5S,6S,9S)-8-(cyclopropylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5S,6S,9R)-8-(cyclopropylmethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5R,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(5R,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(5S,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(4R,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
(1R,9S,10S,11S)-12-ethyl-10-(hydroxymethyl)-5-[(E)-2-phenylethenyl]-11-(piperidine-1-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
4-[(3aR,4R,9bS)-1-[cyclobutyl(oxo)methyl]-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
4-[(3aS,4R,9bR)-1-[cyclobutyl(oxo)methyl]-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
4-[(3aS,4S,9bR)-1-[cyclobutyl(oxo)methyl]-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
(2R,3R,3aS,9bS)-1-(cyclopentylmethyl)-3-(hydroxymethyl)-6-oxo-N-phenyl-7-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2S,3S,3aR,9bR)-1-(cyclopentylmethyl)-3-(hydroxymethyl)-6-oxo-N-phenyl-7-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-4-(trimethylazaniumyl)butanoate
(E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]dec-4-ene-1-sulfonic acid
3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]decane-1-sulfonic acid
(E)-3-hydroxy-2-(undecanoylamino)dodec-4-ene-1-sulfonic acid
(E)-2-(dodecanoylamino)-3-hydroxyundec-4-ene-1-sulfonic acid
(E)-2-(decanoylamino)-3-hydroxytridec-4-ene-1-sulfonic acid
(E)-3-hydroxy-2-(tridecanoylamino)dec-4-ene-1-sulfonic acid
cis-5-(6-Formylhexyl)-trans-4-(cis-1-octenyl)-2,ref.-3-diphenylisoxazolidine
(10S)-10,20-dihydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.02,11.04,9.015,24.018,23]pentacosan-17-one;hydrate
2-[[(4E,8E,12E)-2-acetamido-3-hydroxytetradeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
O-arachidonoylcarnitine
An O-acylcarnitine having arachidonoyl as the acyl substituent.
N-docosanoyltaurine
A fatty acid-taurine conjugate derived from docosanoic acid.
SPHP(23:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(9s,12ar,15r,15as,16r,18as)-16-benzyl-18-hydroxy-9,14,15-trimethyl-5h,6h,7h,8h,9h,10h,12ah,15h,15ah,16h-oxacyclotetradeca[3,2-d]isoindol-2-one
3-{[(1r,2s,4as,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-2-hydroxy-5-[(2-phenylethyl)amino]cyclohexa-2,5-diene-1,4-dione
(2r)-3-[(2r,4e)-4-{[(1s,2r,4ar,6r,8s,8ar)-2-[(2e)-but-2-en-2-yl]-6,8-dimethyl-decahydronaphthalen-1-yl](hydroxy)methylidene}-5-hydroxy-3-oxo-2h-pyrrol-2-yl]-2-hydroxy-2-methylpropanoic acid
(1s,12s,15r,16s,17s,20s)-1,16,20-trimethyl-16-(4-methylpent-3-en-1-yl)-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraen-17-yl acetate
(1r,2r,3ar,3br,5as,7s,9ar,9br,11as)-2,7-dihydroxy-1-[(1s)-1-[(2s,3r,5s)-3-hydroxy-5-methylpiperidin-2-yl]ethyl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-6-one
(3s)-12-[(1-hydroxy-4,6-dimethoxy-3h-isoindol-5-yl)oxy]-2,6,10-trimethyldodeca-6,10-diene-2,3-diol
(1s,2r,5s,7s,10s,11s,14s,15r,16s,17s,20s,22r,24s)-20-(hydroxymethyl)-10,14,16-trimethyl-23-oxa-18-azahexacyclo[12.11.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁴.0¹⁷,²²]pentacosane-7,22-diol
2-[(1-hydroxyhexadecylidene)amino]-3-(4-methoxyphenyl)-2-methylpropanoic acid
alkaloid f3
{"Ingredient_id": "HBIN015170","Ingredient_name": "alkaloid f3","Alias": "NA","Ingredient_formula": "C27H45NO4","Ingredient_Smile": "NA","Ingredient_weight": "447.65","OB_score": "NA","CAS_id": "77410-34-5","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7024","PubChem_id": "NA","DrugBank_id": "NA"}